We are live on ! Find out more
StepStone Group

StepStone Group Portfolio holdings

AUM $1.43B Turnover 54.55%
1-Year Est. Return 22.39%
 

StepStone Group is a private markets firm that builds customized investment portfolios, monitors them and advises investors. Its business spans primary and secondary fund investments plus co-investments, across private equity, real estate, infrastructure, real assets and private debt. Its founders, Monte Brem and Thomas Keck, had earlier made private equity investments at Pacific Corporate Group, as president and managing director respectively. StepStone went public on the Nasdaq in September 2020. The firm serves institutional investors and sponsors worldwide.

This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
-22.39%
3 Year Est. Return
+89.85%
5 Year Est. Return
+3.28%
10 Year Est. Return
+161.9%
AUM
$538M
AUM Growth
-$222M
Cap. Flow
-$200M
Cap. Flow %
-37.09%
Top 10 Hldgs %
96.62%
Holding
26
New
2
Increased
3
Reduced
5
Closed
5
Avg Time Held
1.1 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
1.1 years

Top Buys

Rank Stock Value
1
PCOR icon
Procore
PCOR
+$430K
2
FRSH icon
Freshworks
FRSH
+$233K
3
TWAV icon
TaoWeave
TWAV
+$87
4
HLVX icon
HilleVax
HLVX
+$32
5
CFLT icon
Confluent
CFLT
+$23

Top Sells

Rank Stock Value
1
USER
UserTesting
USER
+$170M
2
IMGO
Imago BioSciences
IMGO
+$18.8M
3
ROVR icon
Rover Group
ROVR
+$8.9M
4
ML icon
MoneyLion
ML
+$1.4M
5
FROG icon
JFrog
FROG
+$512K

Sector Composition

Rank Sector Weight
1 Financials 51.08%
2 Technology 26.47%
3 Industrials 9.74%
4 Healthcare 8.12%
5 Communication Services 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DNB icon
1
DELISTED
Dun & Bradstreet
DNB
$259M 48.09%
22,042,226
– –
2021 Q4
5 quarters
WKME icon
2
DELISTED
WalkMe
WKME
$110M 20.5%
10,366,855
– –
2021 Q3
6 quarters
RKLB icon
3
Rocket Lab
RKLB
$37B
$49.6M 9.21%
12,273,414
– –
2021 Q3
6 quarters
PATH icon
4
UiPath
PATH
$6.46B
$31.4M 5.83%
1,786,527
– –
2021 Q3
6 quarters
RBLX icon
5
Roblox
RBLX
$31.5B
$21M 3.9%
466,666
-2,386
-0.5% -$91.2K
2021 Q3
6 quarters
HLVX icon
6
DELISTED
HilleVax
HLVX
$11.2M 2.08%
676,569
+2
+0% +$32
2022 Q2
3 quarters
TRDA icon
7
Entrada Therapeutics
TRDA
$194M
$11M 2.05%
761,277
– –
2021 Q4
5 quarters
ML icon
8
DELISTED
MoneyLion
ML
$9.6M 1.78%
779,049
-67,110
-8% -$1.4M
2021 Q3
6 quarters
NEUE icon
9
DELISTED
NeueHealth
NEUE
$9.24M 1.72%
525,252
-26
-0% -$1.34K
2021 Q3
6 quarters
NGM
10
DELISTED
NGM Biopharmaceuticals
NGM
$7.9M 1.47%
1,573,357
– –
2021 Q3
6 quarters
DOMA icon
11
DELISTED
Doma Holdings
DOMA
$6.1M 1.13%
595,179
– –
2021 Q3
6 quarters
PHAT icon
12
Phathom Pharmaceuticals
PHAT
$447M
$3.01M 0.56%
422,085
– –
2021 Q3
6 quarters
ROVR icon
13
DELISTED
Rover Group
ROVR
$2.91M 0.54%
643,394
-2,205,946
-77% -$8.9M
2021 Q3
6 quarters
VCSA icon
14
DELISTED
Vacasa
VCSA
$2.83M 0.53%
147,261
-3,430
-2% -$96.2K
2021 Q4
5 quarters
TNYA icon
15
Tenaya Therapeutics
TNYA
$73.6M
$1.32M 0.24%
462,163
– –
2021 Q3
6 quarters
GROV icon
16
Grove Collaborative
GROV
$36.3M
$830K 0.15%
377,345
– –
2022 Q2
3 quarters
PCOR icon
17
Procore
PCOR
$11.2B
$461K 0.09%
+7,353
New +$430K
2023 Q1
0 quarters
TWAV icon
18
TaoWeave
TWAV
$4.54M
$404K 0.08%
6,155
+1
+0% +$87
2021 Q3
6 quarters
FRSH icon
19
Freshworks
FRSH
$3.4B
$236K 0.04%
+15,392
New +$233K
2023 Q1
0 quarters
CFLT icon
20
DELISTED
Confluent
CFLT
$58.9K 0.01%
2,448
+1
+0% +$23
2022 Q4
1 quarter
AMRS
21
DELISTED
Amyris
AMRS
$3.83K ﹤0.01%
2,816
– –
2022 Q4
1 quarter
AMPL icon
22
Amplitude
AMPL
$2.16B
– –
-4,972
Closed -$60.1K –
FROG icon
23
JFrog
FROG
$13.1B
– –
-23,987
Closed -$512K –
SG icon
24
Sweetgreen
SG
$1.45B
– –
-6,379
Closed -$54.7K –
USER
25
DELISTED
UserTesting
USER
– –
-22,680,906
Closed -$170M –

Similar funds

StepStone Group's Q1 2023 Portfolio in Review

As of Q1 2023, StepStone Group held 26 positions worth $538M, down 29% from $760M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

StepStone Group withdrew a net $200M in Q1 2023, closing 5 positions and reducing 5 holdings. Its most notable exit was UserTesting, an estimated $170M position sold in full.

By sector, the portfolio is most concentrated in Financials at 51% of assets, up from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, StepStone Group opened a new position in Procore worth $461K.

  • StepStone Group's largest Q1 2023 buy was Procore: 7,353 shares worth $461K.
  • StepStone Group added most to TaoWeave in Q1 2023, an estimated $87 increase.
  • StepStone Group's biggest Q1 2023 reduction was Rover Group, cutting an estimated $8.9M.
  • StepStone Group fully exited UserTesting in Q1 2023, selling an estimated $170M.
  • StepStone Group's ten largest holdings make up 97% of its $538M portfolio in Q1 2023.
  • StepStone Group opened 2 new positions and closed 5 in Q1 2023.
  • StepStone Group's portfolio value fell 29% quarter-over-quarter to $538M.

Based on StepStone Group's 13F filing for Q1 2023, filed 15 May 2023.